Listed company Liminatus Pharma plans to raise $500 million to invest in BNB
-
最新报道：According to businessinsider, preclinical biopharmaceutical company Liminatus Pharma, Inc. (NASDAQ: LIMN) announced today that it plans to strategically expand into the cryptocurrency and blockchain fields. The company plans to establish a subsidiary called "American BNB Strategy" to lead its digital asset investment and management plan. Through this platform, Liminatus plans to raise and deploy up to $500 million in stages, with the goal of making strategic long-term investments in BNB. Liminatus emphasized that although the company is still fully committed to its core business - advancing the development of cancer treatment and pancreatic cancer diagnostic technology, it believes that expanding into the digital asset field is a necessary measure to support long-term growth and enhance shareholder value. Liminatus is a preclinical biopharmaceutical company dedicated to developing immunotherapies for cancer patients. The company is advancing a series of new therapies targeting cancer antigens and tumor-specific immune responses.
下一篇
Litecoin Flashes Rare Golden Cross Signal
- Litecoin just formed a rare golden cross on the weekly chart! Last 2 times = massive ralli...
24小时热点
热点专题
407106